CONSTITUENT REPORT
Citronellol
Citronellol is a rosy monoterpene alcohol that appears repeatedly across rose, geranium, citronella, and lemon-eucalyptus style oils in the AromaForge archive. The live evidence base is stronger than for many minor fragrance constituents: public sources support clear registry identity, established use as a fragrance material, EU fragrance-allergen labeling relevance, and several preclinical anti-inflammatory, antifungal, and repellent studies. Those activity signals remain mostly cell or animal data rather than human therapeutic evidence, so archive copy should frame citronellol as a well-characterized aroma constituent with preclinical research interest and practical formulation-safety relevance.
Chemical identity and composition
NIST lists citronellol with formula C10H20O and CAS 106-22-9, while also noting stereoisomeric forms under the same base structure. In practice, the AromaForge archive encounters citronellol both as a major rose/geranium alcohol and as a supporting alcohol in citronella and eucalyptus citriodora profiles.
Aroma and practical use
- Use the recorded rosy, floral, fresh, citrus-tinged, sweet, rose-like, citrus descriptors to explore a blend's scent character; perceived strength also depends on the other ingredients.
- Compare the recorded goal signals with the intended purpose, while keeping model assumptions separate from observed study outcomes.
- Review the flagged use concerns across every contributing oil and the selected dilution.
- Read the route, preparation and experimental context before using a study finding to choose an oil.
Reported benefits and effects
Findings retain their study context. An animal or laboratory result describes that experiment.
A 2012 rodent study reported that citronellol reduced nociceptive and inflammatory responses in mice and rats.
The PubMed abstract describes reduced acetic-acid writhing, lower formalin-phase pain behavior, anti-edematogenic activity, and anti-inflammatory effects across standard rodent assays.
This experimental finding does not establish benefit, dose or safety in people using this blend.
A 2010 cell study found that citronellol decreased LPS-induced nitric oxide production and significantly attenuated COX-2 expression in macrophages.
The PubMed abstract reports that citronellol inhibited nitric oxide accumulation and lowered COX-2 protein and mRNA expression in RAW 264.7 cells.
This experimental finding does not establish benefit, dose or safety in people using this blend.
A 2019 Candida paper reported that beta-citronellol altered cell-surface properties and decreased virulence-associated fungal behaviors.
The abstract states that beta-citronellol inhibited morphological transition and reduced secretion of hydrolytic enzymes involved in early pathogenicity of Candida albicans.
This experimental finding does not establish benefit, dose or safety in people using this blend.
A 2020 study on beta-citronellol enantiomers reported inhibition of Candida biofilm formation.
The PubMed abstract reports that all tested concentrations of the beta-citronellol isomers inhibited biofilm formation by Candida albicans and Candida tropicalis.
This experimental finding does not establish benefit, dose or safety in people using this blend.
How it contributes to goal calculations
Model markers guide the formulation score. They are separate from the source findings above.
Use concerns and concentration limits
Sensitization concernFlagged
Flagged in the constituent reference; assess the source, route and finished-product concentration.
Phototoxicity concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Oxidation concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Penetration enhancementNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
A recorded constituent reference, not a recommended oil dilution. Product category, source applicability and all contributing oils must be checked before use.
unverified reference · No source provenance attachedCitronellol is included among EU cosmetic fragrance allergens and must be labeled above 0.001% in leave-on products and 0.01% in rinse-off products.
The source assessment applies to its specified exposure and preparation; this entry is not an unrestricted-use clearance.
No direct public citation is attached to this entry.
SCCS discussion of fragrance allergens highlights citronellol and citronellyl acetate as a corresponding example of oxidation and hydrolysis-related cross-reactive allergen systems.
The source assessment applies to its specified exposure and preparation; this entry is not an unrestricted-use clearance.
No direct public citation is attached to this entry.
Most benefit-facing citronellol evidence remains preclinical, so consumer-facing archive copy should avoid turning anti-inflammatory, antifungal, or repellent findings into medical claims.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
Constituents it may interact with
These are research candidates recorded in the interaction matrix. They do not add a proven-amplification bonus to the score.
GeraniolOpposing candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
animal · effect
No source citation attached.
Read Geraniol report →citronellalAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read citronellal report →GeraniolOpposing candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read Geraniol report →How the effects were investigated
reduction of nitric oxide and COX-2 signaling in activated macrophage models
A PubMed-indexed in vitro study reported that citronellol attenuated LPS-induced nitric oxide production and lowered COX-2 protein and mRNA expression in RAW 264.7 cells.
This experimental finding does not establish benefit, dose or safety in people using this blend.
suppression of inflammatory edema pathways in rodent models
Rodent abstract data describe lower paw edema, leukocyte migration, and nociceptive readouts after citronellol treatment, which supports inflammation-modulating interpretation without establishing human efficacy.
This experimental finding does not establish benefit, dose or safety in people using this blend.
interference with Candida virulence behaviors
Candida studies report that beta-citronellol altered cell-surface hydrophobicity, reduced filamentation, and lowered biofilm-related behavior, indicating a plausible anti-virulence mechanism in vitro.
This experimental finding does not establish benefit, dose or safety in people using this blend.
What this report cannot establish
- A reported constituent percentage does not establish an effective human therapeutic dose or the amount absorbed into the body.
- The presence of a constituent does not guarantee a clinical benefit, rash treatment or sleep improvement from a custom blend.
- An unflagged concern or missing use limit does not establish safety for ingestion, inhalation, skin exposure or a particular person.
- A candidate constituent interaction does not establish that two oils amplify one another at the selected proportions.
- Constituent descriptors alone do not establish a precise top, heart or base lifetime in a finished blend.
Known data gaps (6)
- This pass did not verify a constituent-specific standalone IFRA dermal maximum for isolated citronellol from a primary public source.
- Most direct bioactivity evidence is from cell, fungal, or rodent models rather than human trials on isolated citronellol.
- The archive includes both bulk citronellol and stereoisomer-specific naming contexts, but the reviewed public sources were used mainly at the bulk-constituent level.
- The numeric dermal reference lacks source provenance; a verified flag alone is insufficient.
- Some findings do not record an explicit exposure route; consult the linked study before applying them to a use.
- Interaction candidates lack an attached source citation and remain unqualified.